/Investor DB

Mubadala Capital — 2025 Investments

7 investments dated 2025 · listed companies and verified rows first · show all

Anacondaanaconda.comin𝕏Jul 2025 · $150M

Anaconda provides a secure, governed platform for building and deploying AI at scale, using open-source software and the Conda package manager to ensure compatibility and reproducibility across development and production environments.

AI & Machine LearningData & InfrastructureDeveloper Tools

Peter Wang(Founder)inTravis OliphantinTravis E. Oliphant(Founder)in

Co-investorsBuildGroupIn-Q-TelSnowflake VenturesCiti VenturesInsight Partners

Crusoecrusoe.aiin𝕏Oct 2025 · $3.9B

Crusoe builds energy-first AI infrastructure, using innovative and renewable energy sources to power hyperscale AI factories and a cloud platform for AI workloads.

AI & Machine LearningCloud ComputingData & InfrastructureEnergyDenver, US

Cully Cavness(Founder)inChase Lochmiller(Founder)inCharles Cavness(Executive Officer, Director)Matthew DeNezza(Executive Officer)inJamey Seely(Executive Officer)inMichael Gordon(Executive Officer)in

Co-investorsAbstract VenturesACTIVATE CAPITAL PARTNERSAdvaita CapitalAir Street CapitalAkkaAlkeon Innovation+74 more

Paradigm Healthparadigmhealth.aiinDec 2025 · $78M

Paradigm Health provides technology and services that integrate with healthcare provider organizations to improve the clinical trial process.

AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesSaaSColumbus, US

Kent Thoelke(Founder)inJonathan Hirsch(Chief Strategy and Growth Officer)Jay Trepanier(Chief Financial Officer)inElijah Meerson(Chief Technology Officer)inMichelle Lee(Chief Operating Officer)in

Co-investorsARCH Venture PartnersGeneral CatalystGV (Google Ventures)Lux CapitalF-Prime CapitalJobsOhio Ventures+2 more

Paradigm Healthmyparadigmhealth.cominDec 2025 · $78M

Paradigm Health is an Indiana-based hospice and palliative care provider offering community-based, holistic care to patients and support for their families and caregivers.

Digital HealthHealthtechWellness & Fitness

Jeff Jarecki(Founder & Chairman)in

Co-investorsCressey & CompanyHavencrest Capital ManagementARCH Venture PartnersF-Prime CapitalGeneral CatalystGV (Google Ventures)+1 more

Tenvietenvie.cominJan 2025

Tenvie is a clinical-stage biopharmaceutical company developing small molecule and biologic therapeutics for neurological and peripheral diseases.

BiotechMedical Devices

Tony Estrada(President & Chief Executive Officer; co-founder)in

Co-investorsARCH Venture PartnersF-Prime CapitalBain Capital Life SciencesDigitalis VenturesForbion

Westbound Equity Partnerswestboundequity.comin𝕏Sep 2025 · $7.5M

Westbound Equity is an investment firm with a team spanning technology, social impact, investing, culture, and talent development, supported by an Investment Advisory Committee of investors and operators who advise the firm and its portfolio founders.

Impact & Social GoodSector Agnostic

Co-investorsFoundryNext Play VenturesNext Legacy PartnersSixth StreetTTV Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ollin Biosciences, Inc.

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.